In the Dermani Medspa FDD, under what circumstances might the Business Associate be considered a 'business associate' of the Covered Entity?
Dermani_Medspa Franchise · 2025 FDDAnswer from 2025 FDD Document
III. Permitted Uses and Disclosures by Business Associate
a. Required by Law. Business Associate may use or disclose PHI as Required by Law.
- b. To Carry Out Engagement. Except as otherwise limited in this Agreement, for purposes of the services provided as part of the Engagement, Business Associate may use or disclose PHI solely to perform functions, activities, or services for, or on behalf of, Covered Entity, provided that such use or disclosure would not violate the Regulations if done by Covered Entity.
- c. Management and Administration. Except as otherwise limited in this Agreement, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate, as provided in 45 C.F.R. § 164.504(e)(4). In addition, Business Associate may disclose PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate, provided that such disclosures are Required by Law or Business Associate obtains, prior to the disclosure, reasonable assurances from the person to whom it is disclosed that such PHI will be held secure and confidential as provided pursuant to this Agreement and only disclosed as Required by Law or for the purposes for which it was disclosed to the third party, and that any breaches of confidentiality of the PHI which becomes known to such third party will be immediately reported to Business Associate.
- d. Data Aggregation. Business Associate may use PHI to provide data aggregation services related to the health care operations of the Covered Entity as permitted by 45 C.F.R. § 164.504(e)(2)(i)(B).
- e. De-Identification. Business Associate may use PHI to create information that is deidentified. Any such de-identification by Business Associate will be done in compliance with 45 C.F.R. § 164.514(b). Covered Entity agrees that de-identified information may be used and disclosed on Business Associate's own behalf. Covered Entity agrees that any de-identified information is and will remain the sole property of Business Associate and, due to the regulatory treatment of de-identified information, is no longer PHI and not subject to this Agreement or the Regulations.
Source: Item 23 — RECEIPTS (FDD pages 66–311)
What This Means (2025 FDD)
According to the 2025 Dermani Medspa Franchise Disclosure Document, the Business Associate may use or disclose Protected Health Information (PHI) to perform functions, activities, or services for, or on behalf of, the Covered Entity, provided that such use or disclosure would not violate the Regulations if done by the Covered Entity. This arrangement is specifically for services provided as part of the Engagement. The Business Associate may also use PHI for the proper management and administration of its own business or to fulfill its legal responsibilities, as outlined in 45 C.F.R. § 164.504(e)(4). However, any disclosures for these purposes require reasonable assurances that the PHI will be kept secure and confidential, and that any breaches of confidentiality will be immediately reported to the Business Associate.
Furthermore, the Business Associate is permitted to use PHI to provide data aggregation services related to the healthcare operations of the Covered Entity, as allowed by 45 C.F.R. § 164.504(e)(2)(i)(B). The Business Associate can also use PHI to create de-identified information, provided that this de-identification complies with 45 C.F.R. § 164.514(b). The FDD stipulates that any de-identified information becomes the sole property of the Business Associate and is no longer subject to the agreement or regulations governing PHI.
These provisions ensure that the Business Associate can perform necessary functions while adhering to privacy regulations. Dermani Medspa franchisees should understand these permitted uses and disclosures to ensure compliance with HIPAA and related regulations. The Covered Entity must also inform the Business Associate of any privacy practices, revocations of permission, or restrictions on use and disclosure of PHI that may affect the Business Associate's permitted or required actions. The Covered Entity cannot request the Business Associate to use or disclose PHI in any manner that would be impermissible under the Regulations if done by the Covered Entity.